Genesys International Corporation Limited has informed the Exchange regarding allotment of 1739625 securities pursuant to Qualified Institution Placement at its meeting held on May 17, 2025
GENESYS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genesys International has allotted 17,39,625 equity shares of face value ₹5 each to qualified institutional buyers at an issue price of ₹632.32 per share, raising ₹110 crores through a QIP. The issue price carries a premium of ₹627.32 per share, well above face value, indicating strong investor demand. As a result, the company's paid-up equity share capital has increased from ₹19.94 crore (3,98,84,437 shares) to ₹20.81 crore (4,16,24,062 shares), implying a dilution of about 4.4%. Notable allottees include Unico Global Opportunities Fund (26.05%), BOFA Securities Europe SA (17.06%), BNP Paribas Financial Markets (15.51%), Niveshaay Hedgehogs Fund (11.36%), Nuvama Multi Asset Strategy Return Fund (9.09%), and Niveshaay Sambhav Fund (9.09%). The QIP committee meeting approving the allotment was held on May 17, 2025.
The successful QIP at a significant premium with marquee global investors like BNP Paribas and Bank of America signals strong institutional confidence in the company, though the ~4.4% equity dilution may weigh on short-term stock sentiment.